Plumbago zeylanica Linn. (Sheetraj): A Comprehensive Review of Unani Perspectives, Phytochemistry, and Pharmacological Activities
Abstract
Background: Plumbago zeylanica Linn. (Sheetraj/Chitrak) is an important medicinal plant of the family Plumbaginaceae and has been widely used in the Unani system of medicine for centuries. It is traditionally prescribed for various dermatological, gastrointestinal, inflammatory, and musculoskeletal disorders.
Objective: To review the classical Unani literature and modern scientific evidence related to the pharmacognosy, phytochemistry, pharmacological activities, and therapeutic applications of Plumbago zeylanica.
Methods: A comprehensive literature search was conducted using classical Unani texts and electronic databases including PubMed, Google Scholar, and ScienceDirect. Relevant publications up to 2025 were reviewed and analyzed.
Results: Unani literature describes Sheetraj as Garm wa Khushk (Hot and Dry) in the third degree with actions such as anti-inflammatory, digestive, expectorant, diuretic, and nervine stimulant. Phytochemical investigations have identified plumbagin as the principal active constituent along with coumarins, flavonoids, sterols, and other bioactive compounds. Experimental and clinical studies have demonstrated antimicrobial, wound-healing, antiulcer, antihyperlipidemic, antidiabetic, hepatoprotective, nephroprotective, anti-inflammatory, antiobesity, antifertility, and anticancer activities, supporting many of its traditional uses.
Conclusion: The available evidence validates several classical Unani claims regarding Sheetraj and highlights its significant therapeutic potential. Further clinical studies are required to establish its safety, efficacy, and standardization for evidence-based clinical applications.
Keywords: Plumbago zeylanica, Sheetraj, Chitrak, Unani medicine, plumbagin, phytochemistry, pharmacology.
Keywords:
Plumbago zeylanica, Sheetraj, Unani medicine, pharmacology, herbal medicineDOI
https://doi.org/10.22270/jddt.v16i7.7863References
1. Pendurkar RS, Mengi AS. Anti-hyperlipidemic effect of aqueous extract of Plumbago zeylanica roots in diet-induced hyperlipidemic rat. Pharmaceutical Biology.2009;47(10):1004-1010. https://doi.org/10.1080/13880200902973779
2. Tokarz KM, Makowski W, Tokarz B et al. Can Ceylon Leadwort (Plumbago zeylanica L.) Acclimate to Lead Toxicity?-Studies of Photosynthetic Apparatus efficiency. International Journal of Molecular Science. 2020; 21(5):1866. https://doi.org/10.3390/ijms21051866 PMid:32182862 PMCid:PMC7084747
3. Madhava Chetty K, Lakshmipathi Chetty M, Sudhakar A, Ramesh C. Ethno-medico Botany of some a quatic Angiospermae in Chittoor district of Andhra Pradesh, India. Fitoterapia 1998; 69:7 12.
4. Anonymas. Agro-techniques of selected medicinal plants. Vol.1. New Delhi: Department of AYUSH; Ministry of Health and Family Welfare, Govt. of India; 2008: p.145-49.
5. Patwardhan RB. Challenges and Perspectives on Plasmid Curing, Medicinal and Pharmacological Traits of Plumbago zeylanica (Chitraka): A Review. International Journal of Life science and Pharma Research. 2020; 10(5): p.139-153. https://doi.org/10.22376/ijpbs/ijlpr.2020.10.5.P139-153
6. Choudhary S, Kaurav H, Chaudhary G. Citraka (Plumbago zeylanica): A Potential Rejuvenator. International Journal for Research in Applied Sciences and Biotechnology. 2021; 8 (2):202-212. https://doi.org/10.31033/ijrasb.8.2.26
7. Khare C.P. Indian medicinal plants. New Delhi: Springer (India); 2007.p. 501. https://doi.org/10.1007/978-0-387-70638-2 PMCid:PMC2705749
8. Nadkarni KM. Indian Materia Medica. Vol-1.Bombay: Popular Parkashan; 1976. 2010:990.
9. Khan MA. Muheet Azam, V. III. New Delhi: CCRUM; 2014. p. 418.
10. Kabeeruddeen M. MakhzanulMufradat. New Delhi: Idarakitabusshifa; 2007. p. 196-197.
11. Hakeem MA. Bustan al- Mufaradat. New Delhi: Idara kitab-us-Shifa; 2002. p. 249.
12. Kirtikar KR, Basu BD. Indian Medicinal Plants. Vol. II. Dehradun: Connaught Palace; 1991.p. 736, 737.
13. Anonymous. The Wealth of India. Vol. VIII. New Delhi: CSIR; 2009. p.163.
14. Gupta A.K, Tandon N. Quality Standards of Indian Medicinal Plants. New Delhi: Indian council of medical research; 2011. Vol. VII, IX. p.218.
15. Prajapati ND, Purohit SS, Sharma AK, Kumar T. A Handbook of Medicinal Plants. 1st ed. Jodhpur: Agrobios (India); 2009. p. 410.
16. Kabeeruddin H. Makhzan-ul-mufardat Almarufkhavasul Adviya. New Delhi: Ejaz publishing house; YNM. p. 251.
17. Joy PP, Thomas J, Mathew S, Skaria PB. Medicinal Plants. Kerala: Aromatic and Medicinal Plants Research Station; 1997: p. 104.
18. Tariq NA. Taj al-mufardat. New Delhi: Idara Kitab-us-Shifa; 2010. p.325-327.
19. Ghani HN. Khazainul Advia. New Delhi: Idara Kitab-ul-Shifa; 2011. P. 635-636.
20. Ibn al-Baytar ZA. Makhzan al-Adwiyah wa al-Aghziya. Urdu translation. Vol 3. New Delhi: Central Council for Research in Unani Medicine (CCRUM); 1999. P.161 162.
21. Iyengar MA. Pendse GS. Plumbago zeylanica L. (Chitrak) A Gastro-Intestinal Flora Normaliser. 1966;14 (3):337-351. https://doi.org/10.1055/s-0028-1100060 PMid:6013406
22. William D, Warden CJ, David H. Pharmacographia Indica; a history of the principle drugs of vegetable origin. Vol. II. New Delhi: Srishti book distributors; 2005.p.328-334.
23. Chopra NR, Nayar LS, Chopra CI. Glossary of Indian Medicinal Plants. 1st ed. New Delhi: CSIR; 2002. p. 197.
24. Rajakrishnan R, Lekshmi R, Benil PB, Thomas J, AlFarhan AH. Rakesh V, Khalaf S. Phytochemical evaluation of roots of Plumbago zeylanica L. and assessment of its potential as a nephroprotective agent. Saudi Journal of Biological Sciences. 2017; 24(4):760-766. https://doi.org/10.1016/j.sjbs.2017.01.001 PMid:28490944 PMCid:PMC5415120
25. Mandavkar YD, Jalalpure SS. A comprehensive review on Plumbago zeylanica Linn. African journal of Pharmacy and Pharmacology African Journal of Pharmacy and Pharmacology. 2011;5(25):2738-2747. https://doi.org/10.5897/AJPP11.739
26. Government of India, Ministry of Health & Family Welfare, Department of AYUSH. The Unani Pharmacopoeia of India. Part I, Vol I. New Delhi: Government of India; 2007. P.80-81.
27. Saifuddin A. Unani Adviya Mufarda. New Delhi: Central council for Promotion of Urdu Language; 2004. p. 197-98.
28. Rafiquddin M. Kunjul Adviyamufrada. Aligarh: AMU; 1985: p. 466-67.
29. Multani HC. Hindustan aur Pakistan ki jadibutiya aur unkfavaid. Lahor: Maktaba Danyal; p.452 454.
30. Hakeem MK. Byaze Kabeer New Delhi: Idara Kita al-Shifa; 2010. p.12, 15, 54, 180, 187.
31. Sharma A, Singh N. A multifarious potent herb: Plumbago zeylanica: a mini review. Int J Recent Sci Res. 2015;6(6):4825-9.
32. Arpita R, Navneeta B. A review on pharmaceutically important medical plant: Plumbago zeylanica. J Ayu Herb Med. 2017;3(4):225-8. https://doi.org/10.31254/jahm.2017.3411
33. Datta S, Mishra RN. In-vitro antioxidant activities of Plumbago zeylanica Linn and Plumbago rosea Linn: a comparative study. Int J Pharmacogn Phytochem. 2014;6(3):531-5.
34. Ming Y. Chemical constituents of Plumbago zeylanica. Adv Mater Res. 2011;308310:1662-4. https://doi.org/10.4028/www.scientific.net/AMR.308-310.1662
35. Kishore N, Mishra BB, Tiwari VK, Tripathi V. An account of phytochemicals from Plumbago zeylanica (family: Plumbaginaceae): a natural gift to human being. Chron Young Sci. 2012;3:178-98. https://doi.org/10.4103/2229-5186.99564
36. Kishore N, Mishra BB, Tiwari VK, Tripathi V. A novel naphthaquinone from Plumbago zeylanica L. roots. Chem Nat Compd. 2010;46(4):517-9. https://doi.org/10.1007/s10600-010-9666-6.
37. Kishore N, Mishra BB, Tiwari VK, Tripathi V. Difuranonaphthoquinone from Plumbago zeylanica L. roots. Phytochem Lett. 2010;3(2):62-5. https://doi.org/10.1016/j.phytol.2009.11.007
38. Ariyanathan S, Saraswathy A, Rajamanickam GV. Quality control standards for the roots of three Plumbago species. Indian J Pharm Sci. 2010;72(1):86-91. https://doi.org/10.4103/0250-474X.62254. PMid:20582195 PMCid:PMC2883232
39. Dhale DA, Markandeya SK. Antimicrobial and phytochemical screening of Plumbago zeylanica leaf. J Exp Sci. 2011;2(3):04-6
40. Shukla, B., Saxena, S., Usmani, S. et al. Phytochemistry and pharmacological studies of Plumbago zeylanica L.: a medicinal plant review. Clin Phytosci 7, 34 (2021). https://doi.org/10.1186/s40816-021-00271-7.
41. Kodati D, Shashidher B, Galipelly SK, Kumar GP. Evaluation of wound healing activity of methanolic root extract of Plumbago zeylanica L. in wistar albino rats. Asian J Plant Sci Res. 2011;1:26-34.
42. Pendurkar RS, Mengi SA. Antihyperlipidemic effect of aqueous extract of Plumbago zeylanica roots in diet-induced hyperlipidemic rat. Pharm Biol. 2009;47(10):1004-10. https://doi.org/10.1080/13880200902973779
43. Falang KD, Uguru MO, Wannang NN, Azi IH, Chiamaka N. Antiulcer activity of Plumbago zeylanica Linn root extract. J Nut Prod Plant Resour. 2012;2(5):563-7.
44. Singh M, Pandey A, Sawarkar H, Gupta A, Gidwani B, Dhongade H, et al. Methanolic extract of Plumbago zeylanica: a remarkable antibacterial agent against many human and agricultural pathogens. Aust J Pharm. 2017;1:18-22. https://doi.org/10.3831/KPI.2017.20.004 PMid:28392958 PMCid:PMC5374334
45. Sheeja E, Joshi SB, Jain DC. Bioassay-guided isolation of anti-inflammatory and antinociceptive compound from Plumbago zeylanica leaf. Pharm Biol. 2010;48(4):381-7. https://doi.org/10.3109/13880200903156424.Return to ref 30 in article https://doi.org/10.3109/13880200903156424 PMid:20645715
46. Aleem M. Anti-inflammatory and antimicrobial potential of Plumbago zeylanica L: a review. J Drug Deliv Ther. 2020;10(5-s):229-35. https://doi.org/10.22270/jddt.v10i5-s.4445.
47. Arunachalam KD, Velmurugan P, Raja RB. Anti-inflammatory and cytotoxic effects of extract from Plumbago zeylanica. African J Microbiol Res. 2010;4(12):1239-45.
48. Thanigavelan V, Venkatachalam K, Venkatachalam L, Natarajan S, Murugan PK, Savarimuthu JA. Hydroalcoholic extract of Plumbago zeylanica Linn root bark exhibit analgesic and anti-inflammatory activities in experimental rat models. Am J Pharm Health Res. 2014;2(4):209-21.
49. Zarmouh MM, Subramaniyam K, Viswanathan S, Kumar PG. Cause and effect of Plumbago zeylanica root extract on blood glucose and hepatic enzymes in experimental diabetic rats. Afr J Microbio Res. 2010;4(24):2674-7.
50. Kotecha M, Rao KS. Clinical evaluation of. Haridra & chitrak in the management of medoroga (obesity). J Ayurveda. 2007;1:226-8.
51. Kanchana N, Sadiq AM. Hepatoprotective effect of Plumbago zeylanica on paracetamol induced liver toxicity in rats. Int J Pharm Pharmaceut Sci. 2011;3:151-4.
52. Rajakrishnan R, Lekshmi R, Benil PB, Thomas J, Farhan AH, Rakesh V, et al. Phytochemical evaluation of roots of Plumbago zeylanica L. and assessment of its potential as a nephroprotective agent. Saudi J Biol Sci. 2017;24(4):760-6. https://doi.org/10.1016/j.sjbs.2017.01.001. PMid:28490944 PMCid:PMC5415120
53. Edwin S, Siddheswar JB, Dharam CJ. Antifertility activity of leaves of Plumbago zylanica Linn. In female albino rats. Eur J Contracept Reprod Health Care. 2009;14:273-7. https://doi.org/10.1080/13625180902874310 PMid:19565421
54. Eldhose B, Gunawan M, Rahman M, Latha MS, Notario V. Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis. Int J Oncol. 2014;45(5):1913-20. https://doi.org/10.3892/ijo.2014.2592. PMid:25109615 PMCid:PMC4203329
55. Mani H, Jayachitra A. Anti-cancer activity of ethanolic extract of Plumbago zeylanica against dalton’s ascitic lymphoma in mice. Int J Appl Eng Res. 2019;14(7):1715-21.
Published
Abstract Display: 0
PDF Downloads: 0
PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Malik Kashif, Abdul salaam

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.